Pharmaceuticals, Biotechnology & Life Sciences

Aphios Pharma LLC

Regulation Crowdfunding campaign information and financial data from SEC filings


Profile

According to their SEC filings, Aphios Pharma LLC is a Limited Liability Company organized in DE on 07-06-2018. They report having 2 employees, and revenue in their most recent fiscal year of $0 and $0 the prior year.

Description:
Aphios is developing enabling technology platforms designed to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Using these enabling technology platforms, Aphios and its collaborators are developing enh...
Website:
www.aphios.com
Location:
3-E Gill Street
Woburn, MA 01801

Equity Crowdfunding Campaigns

Active Offering

Aphios Pharma LLC is currently raising a target of $10,000 (and up to $1,070,000) of Common Stock via NetCapital before a deadline of 11-07-2018.

Intermediary compensation

According to the SEC filings, NetCapital will be directly compensated as follows for this offering:

"Up to 4.9% of amount raised for a successful offering"

In addition to any direct compensation, Aphios Pharma LLC reports that NetCapital will also receive the following financial interest in the offering:

"None."

More information about this issuer may also be available via Crowditz.com, including information about weekly and aggregate investor commitments.

Financial Information

The following information is taken from SEC filings.

Income Statement Items

Most-Recent Fiscal Year Prior Fiscal Year % Change
Revenue $0 $0 N/A
Cost of Goods Sold $0 $0 N/A
Taxes Paid $0 $0 N/A
Net Income $0 $0 N/A

Balance Sheet Items

Most-Recent Fiscal Year Prior Fiscal Year % Change
Total Assets $0 $0 N/A
Cash & Cash Equivalents $0 $0 N/A
Accounts Receivable $0 $0 N/A
Short-Term Debt $0 $0 N/A
Long-Term Debt $0 $0 N/A

Complete Reg CF filing activity feed

  • New Offering Form C

    [ Sep-7 ] Aphios Pharma LLC filed SEC Form C to raise a target amount of $10,000 (up to a maximum of $1,070,000) of Common Stock via NetCapital before a deadline of 11-07-2018.

    Description:

    "Aphios is developing enabling technology platforms designed to improve drug discovery and manufacturing, nanotechnology drug delivery and pathogenic drug safety. Using these enabling technology platforms, Aphios and its collaborators are developing enh..."